MisophoniaNCT07469033
Prevalence of Misophonia in Turkish High School Students
An observational study of Misophonia, run by Ondokuz Mayıs University at 2 sites in Turkey (Türkiye).
Trial summary
This cross-sectional study aims to determine the prevalence of misophonia among high school students in Kayseri and Samsun, Turkey. Data will be collected using a sociodemographic data form and the Amsterdam Misophonia Scale-Revised (AMISOS-R). Read more about this study
- Who is it for?
- Ages 15 to 18 yearsHealthy volunteers can take part
- Conditions the study is for
- Misophonia
- How many people
- 600 participants
- Where
- 2 sitesTurkey (Türkiye)
- Study dates
- 25 Jan 2025to 1 Apr 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 15 to 18 years
- All sexes
- Healthy volunteers accepted
- Child, Adult
Study population: High school students in grades 9 through 12 from selected schools in Kayseri and Samsun, Turkey.
Who may be able to join
- Students enrolled in grades 9 through 12
- Students without diagnosed hearing loss
- Students without chronic illness
- Students without severe psychological disorders
Who cannot join
- Students with diagnosed hearing loss
- Students with any chronic illness
- Students with severe psychological disorders
- Students outside the defined age range
- Students who are illiterate
- Students with intellectual disabilities
Trial locations and contacts
2 sites in 1 country. Contact the study team or a site near you to ask about taking part.
Turkey (Türkiye)2 sites, 2 recruiting
- Recruiting
Selected High Schools in Kayseri
Kayseri
- Recruiting
Selected High Schools in Samsun
Samsun
About this study
Official title: Prevalence of Misophonia in Turkish High School Students: A Sample From Kayseri and Samsun
This cross-sectional study aims to determine the prevalence of misophonia among high school students in Kayseri and Samsun, Turkey. Data will be collected using a sociodemographic data form and the Amsterdam Misophonia Scale-Revised (AMISOS-R). The study will evaluate the frequency and severity of misophonia symptoms and examine their association with demographic variables.
Read the detailed description
Misophonia is a condition characterized by decreased tolerance and heightened sensitivity to specific sounds. It is more closely related to the character of the sound than to its intensity and is often reported to begin during childhood or early adolescence. Misophonia may negatively affect students' social interactions and academic performance, particularly in school environments where exposure to auditory stimuli is unavoidable.
This cross-sectional descriptive prevalence study aims to determine the prevalence and severity of misophonia among high school students in Kayseri and Samsun, Turkey. The study population will include students in grades 9 through 12 attending selected high schools. Students with hearing loss, chronic illness, severe psychological disorders, intellectual disabilities, or those outside the defined age range will be excluded.
Data will be collected using a sociodemographic data form and the 10-item Amsterdam Misophonia Scale-Revised (AMISOS-R), a validated self-report instrument assessing the presence and severity of misophonia symptoms. Statistical analyses will be conducted to evaluate the distribution of misophonia symptoms and their associations with demographic variables. The study will be conducted in accordance with ethical principles.
- Conditions
- Misophonia
- Keywords
- AMISOS-R, High school students, Prevalence
- Medical subject headings
- misophonia
What is being measured
The primary outcome is the main question the study is designed to answer.
Prevalence of misophonia in high school students
The proportion of high school students identified as having misophonia based on predefined classification criteria using the Amsterdam Misophonia Scale-Revised (AMISOS-R). The AMISOS-R total score ranges from 0 to 40, with higher scores indicating greater misophonia severity. Misophonia classification is determined according to established cutoff values.
Measured: Baseline (single assessment)
Secondary outcomes (1)
Severity levels of misophonia symptoms
Distribution of students according to misophonia severity levels (normal, mild, moderate, and severe) based on the Amsterdam Misophonia Scale-Revised (AMISOS-R). The AMISOS-R total score ranges from 0 to 40, with higher scores indicating more severe misophonia symptoms.
Measured: Baseline (single assessment)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Mar 2026
- Study start25 Jan 2025
- Primary completion1 Apr 2026 (estimated)
- Study completion1 Apr 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for MisophoniaStudies of the same condition, open and under way.
- More trials run by Ondokuz Mayıs UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 600 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Ondokuz Mayıs University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Handan Turan Dizdar, Ondokuz Mayıs University
- Investigators
- Asya Sıla Alacahan, Study director, Ondokuz Mayıs University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07469033
- Sponsor's protocol ID
- 2024/581
- Status last verified
- Feb 2026
- First submitted
- 24 Feb 2026
- Last updated
- 13 Mar 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Individual participant data will not be shared.
Study at a glance
From the registry record, last updated by the sponsor on 13 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Prevalence of Misophonia in Turkish High School Students: A Sample From Kayseri and Samsun
- ClinicalTrials.gov ID
- NCT07469033
- Acronym / sponsor ID
- 2024/581
- Conditions
- Misophonia
- Keywords
- AMISOS-R, High school students, Prevalence
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 600 participants (estimated)
- Lead sponsor
- Ondokuz Mayıs UniversityUniversity, hospital or other
- Study start
- 25 Jan 2025 (actual)
- Primary completion
- 1 Apr 2026 (estimated)
- Study completion
- 1 Apr 2026 (estimated)
- First posted
- 13 Mar 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This cross-sectional study aims to determine the prevalence of misophonia among high school students in Kayseri and Samsun, Turkey. Data will be collected using a sociodemographic data form and the Amsterdam Misophonia Scale-Revised (AMISOS-R). The study will evaluate the frequency and severity of misophonia symptoms and examine their association with demographic variables.
Detailed description
Misophonia is a condition characterized by decreased tolerance and heightened sensitivity to specific sounds. It is more closely related to the character of the sound than to its intensity and is often reported to begin during childhood or early adolescence. Misophonia may negatively affect students' social interactions and academic performance, particularly in school environments where exposure to auditory stimuli is unavoidable.
This cross-sectional descriptive prevalence study aims to determine the prevalence and severity of misophonia among high school students in Kayseri and Samsun, Turkey. The study population will include students in grades 9 through 12 attending selected high schools. Students with hearing loss, chronic illness, severe psychological disorders, intellectual disabilities, or those outside the defined age range will be excluded.
Data will be collected using a sociodemographic data form and the 10-item Amsterdam Misophonia Scale-Revised (AMISOS-R), a validated self-report instrument assessing the presence and severity of misophonia symptoms. Statistical analyses will be conducted to evaluate the distribution of misophonia symptoms and their associations with demographic variables. The study will be conducted in accordance with ethical principles.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 15 to 18 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child, Adult
- Study population
- High school students in grades 9 through 12 from selected schools in Kayseri and Samsun, Turkey.
Key inclusion criteria (4 listed)
- Students enrolled in grades 9 through 12
- Students without diagnosed hearing loss
- Students without chronic illness
- Students without severe psychological disorders
Key exclusion criteria (6 listed)
- Students with diagnosed hearing loss
- Students with any chronic illness
- Students with severe psychological disorders
- Students outside the defined age range
- Students who are illiterate
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Prevalence of misophonia in high school students
Time frame: Baseline (single assessment)
The proportion of high school students identified as having misophonia based on predefined classification criteria using the Amsterdam Misophonia Scale-Revised (AMISOS-R). The AMISOS-R total score ranges from 0 to 40, with higher scores indicating greater misophonia severity. Misophonia classification is determined according to established cutoff values.
1 secondary outcome
Severity levels of misophonia symptoms
Time frame: Baseline (single assessment)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Mar 2026.
- Individual participant dataSharing planned: No. Individual participant data will not be shared.
Related trials for Misophonia
Recruiting
Transcranial Magnetic Stimulation in Misophonia
Misophonia
Not yet recruitingObservational study
Pain, Central Sensitization, and Misophonia in Lipedema
Lipedema
Not yet recruiting
Effectiveness of a Mindfulness-Based Cognitive Behavioral Mobile Intervention for Misophonia
Misophonia, Misophonia Treatment
RecruitingEarly Phase 1
Propranolol for Misophonia
Misophonia, Propanolol
Recruiting
Mindfulness Application Effects on Mental Health Symptoms in Children With Severe Tinnitus and Misophonia
Tinnitus, Misophonia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Asya Sıla Alacahan study director
Ondokuz Mayıs University
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Misophonia, run by Ondokuz Mayıs University at 2 sites in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 13 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Handan Turan Dizdar, PhD (+905055970627, handan.dizdar@omu.edu.tr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Prevalence of misophonia in high school students (time frame: Baseline (single assessment)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Mar 2026.